Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
R1 RCM | RCM | Apr 30, 2024 | 12.29 | -0.49 |
Rackspace Technology | RXT | Apr 30, 2024 | 1.72 | -1.71 |
Radcom | RDCM | Apr 30, 2024 | 8.80 | +1.21 |
Radian Group | RDN | Apr 30, 2024 | 29.87 | -1.45 |
Radiant Logistics | RLGT | Apr 30, 2024 | 4.94 | -2.76 |
RadNet | RDNT | Apr 30, 2024 | 48.50 | -1.02 |
Radware | RDWR | Apr 30, 2024 | 16.53 | -2.25 |
Rafael B | RFL | Apr 30, 2024 | 1.59 | -7.56 |
Rail Vision | RVSN | Apr 30, 2024 | 1.02 | -6.42 |
Rallybio | RLYB | Apr 30, 2024 | 1.92 | +3.78 |
Ralph Lauren | RL | Apr 30, 2024 | 163.64 | -2.03 |
Ramaco Resources A | METC | Apr 30, 2024 | 15.68 | -5.31 |
Ramaco Resources B | METCB | Apr 30, 2024 | 11.11 | -3.05 |
Rambus | RMBS | Apr 30, 2024 | 54.82 | -9.36 |
Rand Capital | RAND | Apr 30, 2024 | 14.10 | 0.00 |
Range Resources | RRC | Apr 30, 2024 | 35.91 | -3.91 |
Ranger Energy Services A | RNGR | Apr 30, 2024 | 9.84 | -3.62 |
Rani Therapeutics A | RANI | Apr 30, 2024 | 6.38 | -4.78 |
Ranpak A | PACK | Apr 30, 2024 | 7.24 | -3.60 |
Rapid Micro Biosystems A | RPID | Apr 30, 2024 | 0.98 | +2.09 |
Rapid7 | RPD | Apr 30, 2024 | 44.80 | -1.93 |
RAPT Therapeutics | RAPT | Apr 30, 2024 | 7.70 | -2.28 |
Rare Earth/Str Metals ETF Market Vectors | REMX | Apr 30, 2024 | 50.97 | -3.04 |
Rave Restaurant Group | RAVE | Apr 30, 2024 | 2.05 | -1.20 |
Raymond James Financial | RJF | Apr 30, 2024 | 122.00 | -0.97 |
Raymond James Financial B | RJF-B | Apr 30, 2024 | 25.12 | -0.08 |
Raymond James Sb-1 Equity Guggenheim | RYJ | Apr 30, 2024 | 65.36 | 0.00 |
Rayonier Advanced Materials | RYAM | Apr 30, 2024 | 3.73 | -9.69 |
Rayonier REIT | RYN | Apr 30, 2024 | 29.66 | -1.63 |
RB Global | RBA | Apr 30, 2024 | 71.58 | -2.89 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.